

Senate
File
2360


AN
ACT


CREATING
THE
MEDICAL
CANNABIDIOL
ACT
AND
PROVIDING
PENALTIES.


BE
IT
ENACTED
BY
THE
GENERAL
ASSEMBLY
OF
THE
STATE
OF
IOWA:


Section
1.
Section
124.401,
subsection
5,
Code
2014,
is


amended
by
adding
the
following
new
unnumbered
paragraph
after


unnumbered
paragraph
2:


NEW
UNNUMBERED
PARAGRAPH
.
A
person
may
knowingly
or


intentionally
recommend,
possess,
use,
dispense,
deliver,


transport,
or
administer
cannabidiol
if
the
recommendation,


possession,
use,
dispensing,
delivery,
transporting,
or


administering
is
in
accordance
with
the
provisions
of
chapter


124D.
For
purposes
of
this
paragraph,
“cannabidiol”
means
the


same
as
defined
in
section
124D.2.


Sec.
2.
NEW
SECTION


.
124D.1
Short
title.


This
chapter
shall
be
known
and
may
be
cited
as
the
“Medical


Cannabidiol
Act”
.





Senate
File
2360,
p.
2


Sec.
3.
NEW
SECTION
.
124D.2
Definitions.


As
used
in
this
chapter:


1.
“Cannabidiol”
means
a
nonpsychoactive
cannabinoid
found


in
the
plant
Cannabis
sativa
L.
or
Cannabis
indica
or
any


other
preparation
thereof
that
is
essentially
free
from
plant


material,
and
has
a
tetrahydrocannabinol
level
of
no
more
than


three
percent.


2.
“Department”
means
the
department
of
public
health.


3.
“
Intractable
epilepsy”
means
an
epileptic
seizure


disorder
for
which
standard
medical
treatment
does
not
prevent


or
significantly
ameliorate
recurring,
uncontrolled
seizures
or


for
which
standard
medical
treatment
results
in
harmful
side


effects.


4.
“Neurologist”
means
an
allopathic
or
osteopathic


physician
board-certified
in
neurology
in
good
standing
and


licensed
under
chapter
148.


5.
“Primary
caregiver”
means
a
person,
at
least
eighteen


years
of
age,
who
has
been
designated
by
a
patient’s


neurologist
or
a
person
having
custody
of
a
patient,
as
being


necessary
to
take
responsibility
for
managing
the
well-being


of
the
patient
with
respect
to
the
medical
use
of
cannabidiol


pursuant
to
the
provisions
of
this
chapter.


Sec.
4.
NEW
SECTION


.
124D.3
Neurologist
recommendation
——


medical
use
of
cannabidiol.


A
neurologist
who
has
examined
and
treated
a
patient


suffering
from
intractable
epilepsy
may
provide
but
has
no


duty
to
provide
a
written
recommendation
for
the
patient’s


medical
use
of
cannabidiol
to
treat
or
alleviate
symptoms
of


intractable
epilepsy
if
no
other
satisfactory
alternative


treatment
options
exist
for
the
patient
and
all
of
the


following
conditions
apply:


1.
The
patient
is
a
permanent
resident
of
this
state.


2.
A
neurologist
has
treated
the
patient
for
intractable


epilepsy
for
at
least
six
months.
For
purposes
of
this


treatment
period,
and
notwithstanding
section
124D.2,


subsection
4,
treatment
provided
by
a
neurologist
may
include


treatment
by
an
out-of-state
licensed
neurologist
in
good


standing.


3.
The
neurologist
has
tried
alternative
treatment
options


that
have
not
alleviated
the
patient’s
symptoms.


4.
The
neurologist
determines
the
risks
of
recommending


the
medical
use
of
cannabidiol
are
reasonable
in
light
of
the


potential
benefit
for
the
patient.





Senate
File
2360,
p.
3


5.
The
neurologist
maintains
a
patient
treatment
plan.


Sec.
5.
NEW
SECTION


.
124D.4
Cannabidiol
registration
card.


1.
Issuance
to
patient.
The
department
may
approve
the


issuance
of
a
cannabidiol
registration
card
by
the
department


of
transportation
to
a
patient
who:


a.
Is
at
least
eighteen
years
of
age.


b.
Is
a
permanent
resident
of
this
state.


c.
Requests
the
patient’s
neurologist
to
submit
a
written


recommendation
to
the
department
signed
by
the
neurologist
that


the
patient
may
benefit
from
the
medical
use
of
cannabidiol


pursuant
to
section
124D.3.


d.
Submits
an
application
to
the
department,
on
a
form


created
by
the
department,
in
consultation
with
the
department


of
transportation,
that
contains
all
of
the
following:


(1)
The
patient’s
full
name,
Iowa
residence
address,
date


of
birth,
and
telephone
number.


(2)
A
copy
of
the
patient’s
valid
photo
identification.


(3)
Full
name,
address,
and
telephone
number
of
the


patient’s
neurologist.


(4)
Full
name,
residence
address,
date
of
birth,
and


telephone
number
of
each
primary
caregiver
of
the
patient,
if


any.


(5)
Any
other
information
required
by
rule.


2.
Patient
card
contents.
A
cannabidiol
registration


card
issued
to
a
patient
by
the
department
of
transportation


pursuant
to
subsection
1
shall
contain,
at
a
minimum,
all
of


the
following:


a.
The
patient’s
full
name,
Iowa
residence
address,
and
date


of
birth.


b.
The
patient’s
photo.


c.
The
date
of
issuance
and
expiration
date
of
the


registration
card.


d.
Any
other
information
required
by
rule.


3.
Issuance
to
primary
caregiver.
For
a
patient
in
a


primary
caregiver’s
care,
the
department
may
approve
the


issuance
of
a
cannabidiol
registration
card
by
the
department


of
transportation
to
the
primary
caregiver
who:


a.
Is
at
least
eighteen
years
of
age.


b.
Requests
a
patient’s
neurologist
to
submit
a
written


recommendation
to
the
department
signed
by
the
neurologist
that


a
patient
in
the
primary
caregiver’s
care
may
benefit
from
the


medical
use
of
cannabidiol
pursuant
to
section
124D.3.


c.
Submits
an
application
to
the
department,
on
a
form




Senate
File
2360,
p.
4


created
by
the
department,
in
consultation
with
the
department


of
transportation,
that
contains
all
of
the
following:


(1)
The
primary
caregiver’s
full
name,
residence
address,


date
of
birth,
and
telephone
number.


(2)
The
patient’s
full
name.


(3)
A
copy
of
the
primary
caregiver’s
valid
photo


identification.


(4)
Full
name,
address,
and
telephone
number
of
the


patient’s
neurologist.


(5)
Any
other
information
required
by
rule.


4.
Primary
caregiver
card
contents.
A
cannabidiol


registration
card
issued
by
the
department
of
transportation
to


a
primary
caregiver
pursuant
to
subsection
3
shall
contain,
at


a
minimum,
all
of
the
following:


a.
The
primary
caregiver’s
full
name,
residence
address,
and


date
of
birth.


b.
The
primary
caregiver’s
photo.


c.
The
date
of
issuance
and
expiration
date
of
the


registration
card.


d.
The
full
name
of
each
patient
in
the
primary
caregiver’s


care.


e.
Any
other
information
required
by
rule.


5.
Expiration
date
of
card.
A
cannabidiol
registration
card


issued
pursuant
to
this
section
shall
expire
one
year
after
the


date
of
issuance
and
may
be
renewed.


6.
Card
issuance
——
department
of
transportation.
The


department
may
enter
into
a
chapter
28E
agreement
with
the


department
of
transportation
to
facilitate
the
issuance
of
a


cannabidiol
registration
card
pursuant
to
subsections
1
and
3.


Sec.
6.
NEW
SECTION


.
124D.5
Department
duties
——
rules.


1.
a.
The
department
shall
maintain
a
confidential
file


of
the
names
of
each
patient
to
or
for
whom
the
department


issues
a
cannabidiol
registration
card
and
the
name
of
each


primary
caregiver
to
whom
the
department
issues
a
cannabidiol


registration
card
under
section
124D.4.


b.
Individual
names
contained
in
the
file
shall
be


confidential
and
shall
not
be
subject
to
disclosure,
except
as


provided
in
subparagraph
(1).


(1)
Information
in
the
confidential
file
maintained


pursuant
to
paragraph
“a”
may
be
released
to
the
following


persons
under
the
following
circumstances:


(a)
To
authorized
employees
or
agents
of
the
department
and


the
department
of
transportation
as
necessary
to
perform
the




Senate
File
2360,
p.
5


duties
of
the
department
and
the
department
of
transportation


pursuant
to
this
chapter.


(b)
To
authorized
employees
of
state
or
local
law


enforcement
agencies,
but
only
for
the
purpose
of
verifying


that
a
person
is
lawfully
in
possession
of
a
cannabidiol


registration
card
issued
pursuant
to
this
chapter.


(2)
Release
of
information
pursuant
to
subparagraph


(1)
shall
be
consistent
with
the
federal
Health
Insurance


Portability
and
Accountability
Act
of
1996,
Pub.
L.
No.


104-191.


2.
The
department,
in
consultation
with
the
department
of


transportation,
shall
adopt
rules
to
administer
this
chapter


which
shall
include
but
not
be
limited
to
rules
to
establish


the
manner
in
which
the
department
shall
consider
applications


for
new
and
renewal
cannabidiol
registration
cards.


Sec.
7.
NEW
SECTION


.
124D.6
Medical
use
of
cannabidiol
——


affirmative
defense.


1.
a.
A
recommendation
for
the
possession
or
use
of


cannabidiol
as
authorized
by
this
chapter
shall
be
provided


exclusively
by
a
neurologist
for
a
patient
who
has
been


diagnosed
with
intractable
epilepsy.


b.
Cannabidiol
provided
exclusively
pursuant
to
the


recommendation
of
a
neurologist
shall
be
obtained
from
an


out-of-state
source
and
shall
only
be
recommended
for
oral
or


transdermal
administration.


c.
A
neurologist
shall
be
the
sole
authorized
recommender


as
part
of
the
treatment
plan
by
the
neurologist
of
a
patient


diagnosed
with
intractable
epilepsy.
A
neurologist
shall


have
the
sole
authority
to
recommend
the
use
or
amount
of


cannabidiol,
if
any,
in
the
treatment
plan
of
a
patient


diagnosed
with
intractable
epilepsy.


2.
A
neurologist,
including
any
authorized
agent
thereof,


shall
not
be
subject
to
prosecution
for
the
unlawful


recommendation,
possession,
or
administration
of
marijuana


under
the
laws
of
this
state
for
activities
arising
directly


out
of
or
directly
related
to
the
recommendation
or
use
of


cannabidiol
in
the
treatment
of
a
patient
diagnosed
with


intractable
epilepsy.


3.
a.
In
a
prosecution
for
the
unlawful
possession
of


marijuana
under
the
laws
of
this
state,
including
but
not


limited
to
chapters
124
and
453B,
it
is
an
affirmative
and


complete
defense
to
the
prosecution
that
the
patient
has


been
diagnosed
with
intractable
epilepsy,
used
or
possessed




Senate
File
2360,
p.
6


cannabidiol
pursuant
to
a
recommendation
by
a
neurologist
as


authorized
under
this
chapter,
and,
for
a
patient
eighteen


years
of
age
or
older,
is
in
possession
of
a
valid
cannabidiol


registration
card.


b.
In
a
prosecution
for
the
unlawful
possession
of


marijuana
under
the
laws
of
this
state,
including
but
not


limited
to
chapters
124
and
453B,
it
is
an
affirmative
and


complete
defense
to
the
prosecution
that
the
person
possessed


cannabidiol
because
the
person
is
a
primary
caregiver
of
a


patient
who
has
been
diagnosed
with
intractable
epilepsy
and


is
in
possession
of
a
valid
cannabidiol
registration
card,
and


where
the
primary
caregiver’s
possession
of
the
cannabidiol


is
on
behalf
of
the
patient
and
for
the
patient’s
use
only
as


authorized
under
this
chapter.


c.
(1)
The
defenses
afforded
a
patient
under
paragraph


“a”
apply
to
a
patient
only
if
the
quantity
of
cannabidiol
oil


possessed
by
the
patient
does
not
exceed
thirty-two
ounces.


(2)
The
defenses
afforded
a
primary
caregiver
under


paragraph
“b”
apply
to
a
primary
caregiver
only
if
the
quantity


of
cannabidiol
oil
possessed
by
the
primary
caregiver
does
not


exceed
thirty-two
ounces
per
patient.


d.
If
a
patient
or
primary
caregiver
is
charged
with


the
commission
of
a
crime
and
is
not
in
possession
of
the


person’s
cannabidiol
registration
card,
any
charge
or
charges


filed
against
the
person
shall
be
dismissed
by
the
court
if


the
person
produces
to
the
court
at
the
person’s
trial
a


cannabidiol
registration
card
issued
to
that
person
and
valid


at
the
time
the
person
was
charged.


4.
An
agency
of
this
state
or
a
political
subdivision


thereof,
including
any
law
enforcement
agency,
shall
not


remove
or
initiate
proceedings
to
remove
a
patient
under
the


age
of
eighteen
from
the
home
of
a
parent
based
solely
upon


the
parent’s
or
patient’s
possession
or
use
of
cannabidiol
as


authorized
under
this
chapter.


Sec.
8.
NEW
SECTION


.
124D.7
Penalties.


A
person
who
knowingly
or
intentionally
possesses
or
uses


cannabidiol
in
violation
of
the
requirements
of
this
chapter
is


subject
to
the
penalties
provided
under
chapters
124
and
453B.


Sec.
9.
NEW
SECTION


.
124D.8
Repeal.


This
chapter
is
repealed
July
1,
2017.


Sec.
10.
REPORTS.
The
university
of
Iowa
carver
college
of


medicine
and
college
of
pharmacy
shall,
on
or
before
July
1
of


each
year,
beginning
July
1,
2015,
submit
a
report
detailing





Senate
File
2360,
p.
7


the
scientific
literature,
studies,
and
clinical
trials


regarding
the
use
of
cannabidiol
on
patients
diagnosed
with


intractable
epilepsy
to
the
department
of
public
health
and
the


general
assembly.


______________________________


PAM
JOCHUM


President
of
the
Senate


______________________________


KRAIG
PAULSEN


Speaker
of
the
House


I
hereby
certify
that
this
bill
originated
in
the
Senate
and


is
known
as
Senate
File
2360,
Eighty-fifth
General
Assembly.


______________________________


MICHAEL
E.
MARSHALL


Secretary
of
the
Senate


Approved
_______________,
2014


______________________________


TERRY
E.
BRANSTAD


Governor

